GSK1940029 - 10mM in DMSO , CAS No.1150701-66-8

CAS: 1150701-66-8 Cat. No.: G654585 Peso molecular: 391.25 PubChem CID: 42603008

GRADE & PURITY 10mM in DMSO

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

Descripción general

GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase ( SCD ) inhibitor extracted from patent WO/2009060053 A1, compound example 16.

In Vitro

GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD), which can be used to treat and/or preventing various diseases, including those mediated by SCD enzyme, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming Aβ42 peptide such as Alzheimer's disease. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

IC50& Target:Stearoyl-CoA Desaturase (SCD)

Specifications

Especificaciones y pureza

10mM in DMSO

Mecanismos bioquímicos y fisiológicos

GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase ( SCD ) inhibitor extracted from patent WO/2009060053 A1, compound example 16.

Condiciones de almacenamiento de almacenamiento

Store at -80°C

Enviado en

Dry ice packs + Cold packs

Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.

Nombres e identificadores

• Isómeros SMILES: CC1=C(N=NN1CC2=CC(=C(C=C2)Cl)Cl)C(=O)NC3=CC=C(C=C3)CO
• PubChem CID: 42603008
• Términos de entrada MeSH: 1-(3,4-dichlorobenzyl)-N-(4-(hydroxymethyl)phenyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide;1H-1,2,3-triazole-4-carboxamide, 1-((3,4-dichlorophenyl)methyl)-N-(4-(hydroxymethyl)phenyl)-5-methyl-;GSK1940029
• Peso molecular: 391.25